CD274 and non-small cell lung carcinoma: Therefore, in our study, we investigated the frequencies of genomic alterations and PD-L1 status in patients with primary diagnosed stage I–IIIA NSCLC to elucidate potential biomarkers for precision oncology and to explore the importance of broad-range sequencing in early tumor stages.